Gotham Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 10, 2018
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $54,000,000
Company Info
- Company Description
- Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.
- Market
- Cancer, auto-immune and neurodegenerative diseases
- Location
- New York, New York, USA
- Coinvestors
- Alexandria Real Estate Equities, Celgene Corporation, Forbion Capital Partners, SR One, Versant Ventures